Complete Filing Data
Ark 21Shares Bitcoin ETF reported Unrealized Gain Loss On Investments of -$1.45 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ark 21Shares Bitcoin ETF did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income Loss | -$222.3M | $1.89B |
| Operating Income Loss | -$9.8M | -$5.8M |
| Operating Expenses | $9.8M | $5.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$1.15B | $317.7M | $1.20B | -$587.6M | $1.41B | $46.1M | -$409.2M | $844.6M |
| Operating Income Loss | -$2.2M | -$2.8M | -$2.4M | -$2.4M | -$2.1M | -$1.5M | -$1.6M | -$628.0K |
| Operating Expenses | $2.8M | $2.4M | $2.4M | $1.5M | $1.6M | $721.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Unrealized Gain Loss On Investments | -$1.45B | $1.27B | |
| Gain Loss On Sale Of Other Investments | $1.9M | $825.0K | |
| Stockholders Equity | $3.31B | $4.35B | |
| Gain Loss On Sale Of Investments | $1.9M | $825.0K | |
| Assets Net | $3.31B | $4.35B | $100.00 |
| Retained Earnings Accumulated Deficit | $1.67B | $1.89B | |
| Liabilities | $76.6M | $11.6M | |
| Investment Owned Percent Of Net Assets | $1.00 | $1.00 | |
| Assets | $3.38B | $4.36B | |
| Sponsors Fee Payable | $71.0K | $358.0K | |
| Other Notes Payable | $76.5M | $11.2M | |
| Receivable Investment Sale | $76.5M | $11.2M | |
| Common Stock No Par Value | |||
| Payable Investment Purchase | |||
| Other Receivables | |||
| Unrealized Gain On Sponsor Fee Payable | |||
| Stockholders Equity Period Increase Decrease | $100.00 | ||
| Gain Loss On Investments | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $100.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $100.00 | ||
| Assets Current | $100.00 | ||
| Accounts Payable Fair Value Disclosure |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Unrealized Gain Loss On Investments | -$1.26B | -$136.7M | $859.9M | -$907.3M | $978.4M | -$5.6M | -$543.3M | $845.3M | |
| Gain Loss On Sale Of Other Investments | $168.0K | $666.0K | $593.0K | $497.0K | $500.0K | $83.0K | $327.0K | -$85.0K | |
| Stockholders Equity | $5.09B | $5.03B | $3.92B | $3.21B | $2.85B | $3.16B | -$1.0K | ||
| Gain Loss On Sale Of Investments | $666.0K | $593.0K | $497.0K | $83.0K | $327.0K | ||||
| Assets Net | $5.09B | $5.03B | $3.92B | $3.21B | $2.85B | $3.16B | |||
| Retained Earnings Accumulated Deficit | $2.82B | $2.50B | $1.30B | $481.5M | $435.4M | $844.6M | |||
| Liabilities | $105.9M | $10.4M | $23.9M | $10.6M | $48.4M | $28.3M | |||
| Investment Owned Percent Of Net Assets | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | |||
| Assets | $5.20B | $5.04B | $3.94B | $3.22B | $2.90B | $3.19B | |||
| Sponsors Fee Payable | $124.0K | $200.0K | $754.0K | $1.1M | $770.0K | ||||
| Other Notes Payable | $10.2M | $23.2M | $9.5M | $2.4M | $71.0K | ||||
| Receivable Investment Sale | $10.2M | $23.2M | $9.5M | $2.4M | |||||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Payable Investment Purchase | $105.8M | $45.2M | $27.6M | ||||||
| Other Receivables | $105.8M | $45.2M | $27.6M | ||||||
| Unrealized Gain On Sponsor Fee Payable | $39.0K | ||||||||
| Stockholders Equity Period Increase Decrease | |||||||||
| Gain Loss On Investments | $845.2M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | |||||||||
| Assets Current | |||||||||
| Accounts Payable Fair Value Disclosure | $628.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 |
|---|---|
| Proceeds From Issuance Of Common Stock | $100.00 |
| Net Cash Provided By Used In Financing Activities | $100.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Asset Value Per Share | $29.06 | $31.07 | $16.67 |
| Common Stock Shares Issued | 113.8M | 140.1M | 2.00 |
| Shares Issued | 2.00 | ||
| Sale Of Stock Number Of Shares Issued In Transaction | 2.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $38.00 | $35.81 | $27.42 | $21.13 | $20.63 | $23.58 |
| Common Stock Shares Issued | 134.0M | 140.6M | 47.6M | 50.6M | 46.1M | 44.7M |
| Shares Issued | ||||||
| Sale Of Stock Number Of Shares Issued In Transaction |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Sponsor Fees | $9.8M | $5.9M | |
| Costs And Expenses | $9.8M | $5.8M | |
| Net Realized Gain On Investment In Bitcoin Sold For Redemptions | $1.23B | $621.9M | |
| Stock Issued During Period Shares Period Increase Decrease | -26.3M | 140.1M | 2.00 |
| Stock Issued During Period Shares New Issues | 172.7M | 286.7M | 2.00 |
| Stock Issued During Period Value New Issues | $5.81B | $5.90B | $100.00 |
| Stock Redeemed Or Called During Period Shares | 199.0M | 146.6M | |
| Investment Company Tax Return Of Capital Distribution | $6.64B | $3.44B | |
| Net Realized And Change In Unrealized Gainloss | $1.90B | ||
| Net Investment Income | -$9.8M | -$5.8M | |
| Additional Paid In Capital | $1.64B | $2.46B | |
| Crypto Asset Fair Value | $3.31B | $4.35B | |
| Waiver And Reimbursements | -$93.0K | ||
| Crypto Asset Cost | $3.48B | $3.08B | |
| Net Realized And Change In Unrealized Gain | -$212.5M | $1.90B | |
| Realized Investment Gains Losses | |||
| Net Realized Gainloss On Investment In Bitcoin Sold For Redemptions | |||
| Investment Owned At Cost | |||
| Investment Owned At Fair Value | |||
| Investment Income Net | |||
| Investment Company Increase Decrease From Share Transaction | $100.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Sponsor Fees | $2.2M | $2.8M | $2.4M | $2.4M | $2.1M | $1.5M | $1.6M | $721.0K | |
| Costs And Expenses | $2.2M | $2.8M | $2.4M | $2.4M | $2.1M | $1.5M | $1.6M | $628.0K | |
| Net Realized Gain On Investment In Bitcoin Sold For Redemptions | $116.9M | $456.5M | $339.6M | $321.6M | $433.4M | $53.1M | $135.3M | ||
| Stock Issued During Period Shares Period Increase Decrease | -6.5M | -2.2M | 915.0K | 13.6M | 4.1M | 44.7M | |||
| Stock Issued During Period Shares New Issues | 41.6M | 49.5M | 17.9M | 52.9M | 39.9M | 44.7M | |||
| Stock Issued During Period Value New Issues | $1.57B | $1.60B | $1.69B | $1.10B | $875.8M | $2.32B | |||
| Stock Redeemed Or Called During Period Shares | 48.1M | 51.7M | 16.9M | 39.3M | 35.8M | 10.0K | |||
| Investment Company Tax Return Of Capital Distribution | $1.83B | $1.68B | $1.54B | $789.0M | $777.1M | $419.0K | |||
| Net Realized And Change In Unrealized Gainloss | $1.20B | -$585.2M | $1.41B | $47.6M | -$407.7M | $845.2M | |||
| Net Investment Income | -$2.8M | -$2.4M | -$2.4M | -$1.5M | -$1.6M | -$628.0K | |||
| Additional Paid In Capital | $2.27B | $2.53B | $2.61B | $2.72B | $2.41B | $2.32B | |||
| Crypto Asset Fair Value | $5.09B | $5.03B | $3.92B | $3.21B | $2.85B | ||||
| Waiver And Reimbursements | -$93.0K | ||||||||
| Crypto Asset Cost | $4.00B | $3.55B | $2.55B | $2.55B | |||||
| Net Realized And Change In Unrealized Gain | $320.4M | $47.6M | |||||||
| Realized Investment Gains Losses | $321.6M | -$85.0K | |||||||
| Net Realized Gainloss On Investment In Bitcoin Sold For Redemptions | $321.6M | -$85.0K | |||||||
| Investment Owned At Cost | $2.32B | $2.32B | |||||||
| Investment Owned At Fair Value | $3.16B | ||||||||
| Investment Income Net | -$628.0K | ||||||||
| Investment Company Increase Decrease From Share Transaction |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.